News

Alzheimer's Burden Projected to Double by 2060

Physician's First Watch - Fri, 2018-09-21 05:00
Nearly 14 million Americans aged 65 and older will have Alzheimer disease or related dementias (ADRD) by 2060, according to new estimates from the CDC...
Categories: News

Your NEJM Group Today: Teens & "Pod Mods" / Benefits of Scribes / Wash. State ID Opportunity

Physician's First Watch - Fri, 2018-09-21 05:00
See the latest from NEJM Group: NEJM Primary Care/Hospitalist Page: Perspective: Use of a new e-cigarette product class called "pod mods" is rampant...
Categories: News

Kidney Disease More Common After Premenopausal Oophorectomy

Physician's First Watch - Fri, 2018-09-21 05:00
Women who have both ovaries removed before menopause may face increased risk for chronic kidney disease (CKD), according to a study in the Clinical Journal...
Categories: News

Your NEJM Group Today: Managing Drug Data / Managing Low-Risk PE / Ohio FM Opportunities

Physician's First Watch - Fri, 2018-09-21 05:00
Take a look at today's offering from NEJM Group: NEJM Audio Interview: Managing Data on Drug Effects: Dr. Jerry Avorn discusses the FDA Amendments Act...
Categories: News

Internet CBT May Help Treat Anxiety in Children

Physician's First Watch - Fri, 2018-09-21 05:00
Cognitive behavioral therapy delivered over the internet may be effective in treating anxiety in children, according to a Lancet Child & Adolescent Health study. Swedish researchers...
Categories: News

Higher Gluten Intake in Pregnancy Tied to Increased Diabetes Risk in Offspring

Physician's First Watch - Fri, 2018-09-21 05:00
Higher intake of gluten during pregnancy may be associated with increased risk for type 1 diabetes in offspring, suggests a prospective study in The BMJ...
Categories: News

From the Blogs: Coffee and the State of the Hospital

Physician's First Watch - Fri, 2018-09-21 05:00
You can tell a lot about how things are going in a hospital based on the amount — and type — of coffee consumption by its employees...
Categories: News

FDA Calls for Expanded Opioid Training

Physician's First Watch - Fri, 2018-09-21 05:00
Immediate-release opioids, which account for 90% of all outpatient opioid prescriptions, are now subject to the FDA's Risk Evaluation and Mitigation Strategy (REMS). Previously...
Categories: News

Coca-Cola Looking at Expanding into Cannabis Drinks

Physician's First Watch - Fri, 2018-09-21 05:00
Coca-Cola is looking at entering the cannabis drinks market, Bloomberg reports. The company is discussing development of cannabidiol-infused beverages with Aurora Cannabis, a...
Categories: News

USPSTF: Obese Adults Should Receive Behavioral Interventions

Physician's First Watch - Fri, 2018-09-21 05:00
The U.S. Preventive Services Task Force (USPSTF) is again recommending that obese adults receive intensive behavioral interventions to encourage weight loss (grade B recommendation). In...
Categories: News

As states try to rein in drug spending, feds slap down one bold Medicaid move

News-Medical.Net Pharmaceutical News - Fri, 2018-09-21 04:59
States serve as “laboratories of democracy,” as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
Categories: News

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

News-Medical.Net Pharmaceutical News - Fri, 2018-09-21 00:12
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
Categories: News

New research hub to drive radical change in development and manufacturing of vaccines

News-Medical.Net Pharmaceutical News - Thu, 2018-09-20 22:38
Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.
Categories: News

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

News-Medical.Net Pharmaceutical News - Thu, 2018-09-20 22:09
Non-steroidal anti-inflammatory drugs, or NSAIDs, are commonly used as inflammation blockers worldwide. However, recent clinical data show these painkillers can have serious side effects that create some risk of heart attacks, strokes, and kidney or heart failure.
Categories: News

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

News-Medical.Net Pharmaceutical News - Thu, 2018-09-20 21:45
A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.
Categories: News

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

EurekAlert! - Medicine and Health - Thu, 2018-09-20 21:00
(University of Oxford) Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.
Categories: News

It's not just for kids -- even adults appear to benefit from a regular bedtime

EurekAlert! - Medicine and Health - Thu, 2018-09-20 21:00
(Duke University Medical Center) In a study of 1,978 older adults publishing Sept. 21, 2018, in the journal Scientific Reports, researchers at Duke Health and the Duke Clinical Research Institute found people with irregular sleep patterns weighed more, had higher blood sugar, higher blood pressure, and a higher projected risk of having a heart attack or stroke within 10 years than those who slept and woke at the same times every day.
Categories: News

Outbreak of preventable eye infection in contact lens wearers

EurekAlert! - Medicine and Health - Thu, 2018-09-20 21:00
(University College London) A new outbreak of a rare but preventable eye infection that can cause blindness, has been identified in contact lens wearers in a new study led by UCL and Moorfields Eye Hospital researchers.The research team found a threefold increase in Acanthamoeba keratitis since 2011 in South-East England.
Categories: News

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

News-Medical.Net Pharmaceutical News - Thu, 2018-09-20 06:14
Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.
Categories: News

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

News-Medical.Net Pharmaceutical News - Thu, 2018-09-20 05:34
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
Categories: News
Syndicate content